Sort   by:  
 Page size 
UnknownComment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply.
Not available
S-EPMC11374017 | biostudies-literature
UnknownCOVID-19 vaccination in autoimmune disease (COVAD) survey protocol.
Not available
S-EPMC8591970 | biostudies-literature
UnknownType 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.
Not available
S-EPMC10759717 | biostudies-literature
UnknownBreakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
Not available
S-EPMC11393143 | biostudies-literature
UnknownCOVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
Not available
S-EPMC11343807 | biostudies-literature
UnknownSafety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
Not available
S-EPMC10321116 | biostudies-literature
UnknownDeterminants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study.
Not available
S-EPMC11751688 | biostudies-literature
UnknownCOVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
Not available
S-EPMC11618185 | biostudies-literature
UnknownCOVAD survey 2 long-term outcomes: unmet need and protocol.
Not available
S-EPMC9376047 | biostudies-literature
UnknownDisease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.
Not available
S-EPMC12007600 | biostudies-literature
Sort   by:  
 Page size